, AVENS CIN NO.: Ll7297WB1981PLC034226 13~ovember, 2018 To, The Secretary, The Calcutta Stock Exchange Limited 7, Lyons Range, Kolkata-700 001 Sub: - Submission of Unaudited Financial Result for the rd Quarter ended 30th September,2018 pursuant to Regulation 33 of SEDI (Listing Obligations& Disclosure Requirements), Regulations 2015 Scrip Code: 29065 (CSE Limited) Dear Sir, Pursuant to Regulation 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of the Company held at its Registered Office of the Company on Tuesday, 13th November, 2018 (which commenced at 2.00 P.M. and concluded at 2.40 P.M.) wherein they have approved the following:- 1. Unaudited Financial Results for the 2ndquarter ended 30th September, 2018 pursuant to Regulation33 ofsebi (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Limited Review Report by the Statutory Auditors on Unaudited Financial Result for the 2nd Quarter ended so" September, 2018. The above information are also available on Company's website www.mavensbiotech.com We request you to take on record and acknowledge the same. <~ C~ Thanking you. 0. '~~ rr. -., " r""---",,. ~t... \ For Mavens Biotech L'. ih>,f' <'--~~ '0 "' -r: t:.. 1 _,. \.:. <.. P-- ;.. " > ~,,'\i\ ; ~ I l(o,,..\t,1- I ~ \},_\(. )'11 (Kishan Singh) -.\ ~..:- <, J..JO~0 /'. D irector ' ".:.~ I.. L'-._..; VV -{(,. " DIN: 07526266 '~ Enc!. As Above Registered Office: Room No. 407, Premises 4th Floor, No.4 Clive Row, Kolkata - 700 001.
CIN NO.: Ll7297WB1981PLC034226 Sr. No. MAVENS BIOTECH LIMITED (IN: L17297WB1981PLC034226 Statement of Standalone Unaudited Financial Results for the quarter and balfyear ended 30th September, 2018 PART I (Amount in Rs) Particulars Quarter Ended Half Year Ended Year Ended Unaudited Unaudited Unaudited Unaudited Unaudited Audited (30/09/2018) (30/06/2018) (30/09/2017) (30/09/2018) (30/09/2017) (31/03/2018) 1 Income from operations (a) Net Sales I income from operations (b) Other Income Total income from operations (net) 2 Expenses (a) Changes in inventories of finished goods, work-in progress and stock in trade ~) Employee benefits expense (c) Finance Cost (d) Depreciation and amortisation expense (e) Other expenses Total expenses 3 Profit / (Loss) from operations before Exceptional & Extraordinary Items (1 2) 4 Exceptional & Extraordinary Items 5 Profit / (Loss) before Tax (3 ±4) 6 Tax expense Current Tax Deferred Tax Earlier Years Total Tax Expenses 7 NetProfit/(Loss) after tax(5 ± 6) 8 OtherComprehen~ve Income / (Loss) 9 Total Comprehen~ve Income / (Loss) (7 ± 8) 10 Paid up equity share capital (Face V~ue of the Share shall be indicated)(rs,) 11 Earnings Per Share Basic & Diluted 65,672 65,672 216,823 30,599 233,130 480,552 (414,880) (414,880) 57,342 57,342 246,820 125,733 2,009,181 2,381,734 (2,324,392) (2,324,392) (414,880) (11,462,273) (414,880) (11,462,273) 109,920,000 109,920,000 1 1 (0,00 (0.10 447,000 447,000 359,000 123,014 123,014 236,910 463,643 185,928 457,724 1,239,562 (792,562) (792,562) 156,332 2,242,311 2,862,286 (2,739,272) (2,739,272) (792,562) (11,877,153) 2,067,000 1,757,000 460,000 2,067,000 2,217,000 977,200 1,077,200 545,128 1,245,174 371,857 743,716 939,641 2,676,678 2,833,826 5,742,768 (766,826) (3,525,768) 18,373,580 (766,826) (21,899,348) (131,656) 22,220 (109,436) (766,826) (21,789,912) (792,562) (11,877,153) (766,826) (21,789,912) 109,920,000 109,920,000 109,920,000 109,920,000 ~ ~~ 1 1 /-() '"f e:,~ ~l' //4nJt "..------ ro.111 r '\ (0.01 (0.20 Registered Office: Room No. 407, Premises 4th Floor, No.4 Clive Row, Kolkata - 700 001.
CIN NO.: Ll7297WB1981PLC034226 MAVENS BIOTECH LIMITED CIN:L17297VVB1981PLC034226 Statement of Assets and Liabilities as on 30th September, 2018 SI.No. I A B II A B I II ASSETS Particulars Non-current assets a) Property, plant and equipment b) Financial assets i) Investments ii) Other Non current financial assets c) Other non-current assets Total Non-current assets Current assets a) Inventories b) Financial assets i) Trade Receivables ii) Cash and cash equivalents iii) Loan iv) Other current financial assets Total Current assets TOTAL ASSETS EQUITY AND LIABILITIES EQUITY a) Equity Share capital b) Other Equity Total equity LIABILITIES Non-current liabilities a) Financial liabilities i) Borrowings ii) Other non-current financial liabilities (b) Deferred tax liabilities (net) Total Non-current liabilities Current liabilities a) Financial liabilities b) Other current liabilities c) Current tax liabilities Total Current liabilities TOTAL EQUITY AND LlABILTIIES As at 30th As at 31st March, September, 2018 2018 Unaudited Audited 37,578,018 39,467,108 16,000,000 16,000,000 27,524,208 28,371,521 517,608 520,295 81,619,834 84,358,924 4,446,629 4,446,629 7,259,417 6,464,417 237,564 76,098 2,000,000 2,000,000 3,349,103 4,264,689 17,292,713 17,251,833 98,912,547 101,610,757 109,920,000 (22,621,684) 109,920,000 (10,744,531) 87,298,316 99,175,469 583,577 583,577 583,577 583,577 506,813 10,523,841 465,751 1,385,960 1,851,711 ~r :\,-- 98,912,547.. \ 101,610,757 ~ -- /' Registered Office: Room No. 407, Premises a" Floor, No.4 Clive Row, Kolkata - 700 001.
CIN NO.: L17297WB1981PLC034226 Notes: 1 The above Unaudited Financial results have been reviewed by the Audit committee at their meeting held on 13th November, 2018 and adopted by the Board of Directors at their meeting held on 13th November, 2018. 2 The results are based on the financim statements prepared by the Companys management in accordance with the recognition and measurement principles laid down in the Companies (Indian Accounting Standards] Rules, 2015 (Ind AS] specified under Section 133 of the Companies Act, 2013 read with relevant rules ~sued thereunder. 3 The company is engaged in the business of Trading activities and therefore has only one reportable segment as envisaged by Ind AS 108 'Operating Segment'. 4 The Statutory Auditors of the Company have conducted a limited review of the above unaudited standalone financiru results of the Company for the quarter and hmf year ended September 30, 2018 and issued an unqumified report in this behalf. 5 Provisions for current year income tax and def erred tax will be made at the end of the year except for the earlier year which are accounted on the basis of assessment orders received by the company. 6 Earnings Per Share are not annulised except for the year ended 31st March 2018. 7 Previous period's figures have been regrouped/ reclassified wherever necessary to correspond with the current period's classification/ disclosure. Date: 13th November, 2018 Place: Kolkata,~,r ', : (/) ( y//.. l.1.-, ( ~"TE- ~ By order of the Board ~, 0.--... C' ~or Mavens I~( KOLKf,.TA) p,rc-.~ \\ ~ \.,' _ (Kishan Singh) \ -J \. / " Director, b- tt, ~ _,,. O ~. DIN: 07526266 * Registered Office: Room No. 407, Premises a" Floor, No. 4 Clive Row, Kolkata - 700 001.
CNA'?;ERI D AC COUNIANlS Limited Review Report The Board of Directors, Mavens 1,. 2. We have reviewed the accompanying statement of unaudited financial results of M/s. Mavens ("the Company") for the quarter ended September 30, 2018 together with the notes thereon (the "Statement"). The statement has been prepared by the Company pursuant to the requirements of Regulations 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "listing Regulation,2OI5"), as modified by Circular No. CIR/CFD/FAC/62/ 2OLG dated July 5, 201,6. The Statement is the responsibility of the Company's management and has been approved by the Board of Directors. Further, the Management is also responsible to ensure that the statement has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "lnterim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other recognised accounting principles and policies generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity." issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the Statement has not been prepared in all material respects in accordance with Ind AS and other recognised accounting practices and policies, and has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, 2OI5 read with SEBI circular dated July 05, 2016 including the manner in which it is to be disclosed, or that it contains any material misstatement. For KSA & Co. Chartered Accountants Firm registration p: 003822C Partner Membership No:083399 Place: New Delhi Date: November t3,zotb K-8, Ground Floor, Jangpura Extension, New Delhi-110014 Ph.: +91 1124323155, +91 11 43553157, Mobile: 9811061238 Email: kamalpivush@ksaindia. in, ksaindia@ksaindia. in, Website: www. ksaindia. in Offices at Mumbai, Kolkata, Surat, Bhubaneshwar, Gurgaon